tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Royalty Pharma (RPRX) Revenue

Compare
1,292 Followers

Royalty Pharma Revenue

Royalty Pharma had a revenue of 621.99M in the quarter ending Dec 31, 2025, with 2.08%. This bring the company's revenue in the last twelve months to 2.38B, Decreased 1.21%. In the fiscal year ending Dec 31, 2025, Royalty Pharma had annual revenue of 2.38B with 5.06% growth.
Revenue (ttm)
2.38B
Revenue Growth
3.72%
P/S Ratio
11.07
Revenue/Employee
$31,709,240
Employees
75
Market Cap
$26.34B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.38B114.62M+5.06%
Dec 31, 2024
2.26B-90.98M-3.86%
Dec 31, 2023
2.35B117.34M+5.24%
Dec 31, 2022
2.24B-52.25M-2.28%
Dec 31, 2021
2.29B167.11M+7.87%
Dec 31, 2020
2.12B308.10M+16.98%
Dec 31, 2019
1.81B19.36M+1.08%
Dec 31, 2018
1.79B196.96M+12.33%
Dec 31, 2017
1.60B